• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

对具有三级淋巴结构的三阴性乳腺癌中免疫检查点阻断反应的空间转录组分析。

Spatial transcriptomic analysis of immune checkpoint blockade response in triple negative breast cancers with tertiary lymphoid structures.

作者信息

Mebane Richard H, Noel Teia, Ing Nathan, Gouin Kenneth H, Shah Aagam, Zitser David, Martinez Andrew, Gupta Gaorav, Demaria Sandra, Galluzzi Lorenzo, Ho Alice, McArthur Heather, Shiao Stephen L, Knott Simon R V

机构信息

Department of Biomedical Sciences, Cedars-Sinai Medical Center, Los Angeles, CA, USA.

Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA, USA.

出版信息

iScience. 2025 Jun 2;28(7):112808. doi: 10.1016/j.isci.2025.112808. eCollection 2025 Jul 18.

DOI:10.1016/j.isci.2025.112808
PMID:40599321
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12209978/
Abstract

Tertiary lymphoid structures (TLSs) are associated with improved cancer immunotherapy responses. However, TLSs vary in their ability to elicit anticancer immune activity, so it is important to develop databases that allow study of variables that regulate their function. We applied single RNA molecule resolution imaging to longitudinal biopsies taken from women with TLS-enriched triple negative breast cancers prior to therapy, after pembrolizumab and after pembrolizumab plus radiation therapy. We developed a computational framework to align and analyze spatial trajectories between TLSs and tumor beds. Tumors with higher T cell infiltration rates were eradicated after pembrolizumab. In contrast, those with lower malignant cell and T cell interaction rates at baseline showed CXCL9 macrophage infiltration after pembrolizumab, and infiltration of T cells expressing CXCL9-associated programs prior to cancer cell removal after radiation therapy. This manuscript describes single RNA molecule resolution profiling of breast tumors bearing tertiary lymphoid structures throughout an immunotherapy response.

摘要

三级淋巴结构(TLSs)与癌症免疫治疗反应的改善相关。然而,TLSs引发抗癌免疫活性的能力各不相同,因此开发能够研究调节其功能的变量的数据库非常重要。我们将单RNA分子分辨率成像应用于从富含TLS的三阴性乳腺癌女性患者治疗前、帕博利珠单抗治疗后以及帕博利珠单抗联合放射治疗后的纵向活检样本。我们开发了一个计算框架来对齐和分析TLSs与肿瘤床之间的空间轨迹。帕博利珠单抗治疗后,T细胞浸润率较高的肿瘤被根除。相比之下,那些在基线时恶性细胞与T细胞相互作用率较低的肿瘤在帕博利珠单抗治疗后显示出CXCL9巨噬细胞浸润,并且在放射治疗后癌细胞清除之前有表达CXCL9相关程序的T细胞浸润。本文描述了在整个免疫治疗反应过程中对带有三级淋巴结构的乳腺肿瘤进行单RNA分子分辨率分析的情况。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/91ad/12209978/26e6e2af2f5b/gr6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/91ad/12209978/41676a26a9d7/fx1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/91ad/12209978/acc461199592/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/91ad/12209978/c111f47756b5/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/91ad/12209978/cbf9995e4337/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/91ad/12209978/96b72cc687f0/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/91ad/12209978/ab852edb2ba0/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/91ad/12209978/26e6e2af2f5b/gr6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/91ad/12209978/41676a26a9d7/fx1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/91ad/12209978/acc461199592/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/91ad/12209978/c111f47756b5/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/91ad/12209978/cbf9995e4337/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/91ad/12209978/96b72cc687f0/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/91ad/12209978/ab852edb2ba0/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/91ad/12209978/26e6e2af2f5b/gr6.jpg

相似文献

1
Spatial transcriptomic analysis of immune checkpoint blockade response in triple negative breast cancers with tertiary lymphoid structures.对具有三级淋巴结构的三阴性乳腺癌中免疫检查点阻断反应的空间转录组分析。
iScience. 2025 Jun 2;28(7):112808. doi: 10.1016/j.isci.2025.112808. eCollection 2025 Jul 18.
2
Density of tertiary lymphoid structures predict clinical outcome in hepatoblastoma.三级淋巴结构的密度可预测肝母细胞瘤的临床结局。
Pediatr Res. 2025 Jul 9. doi: 10.1038/s41390-025-04210-x.
3
Systemic treatments for metastatic cutaneous melanoma.转移性皮肤黑色素瘤的全身治疗
Cochrane Database Syst Rev. 2018 Feb 6;2(2):CD011123. doi: 10.1002/14651858.CD011123.pub2.
4
Interferon Regulatory Factor 4 Recruits Immature B Cells to Signal Tertiary Lymphoid Structure Immaturity and Progression of Clear Cell Renal Cell Carcinoma.干扰素调节因子4招募未成熟B细胞以表明三级淋巴结构的不成熟及透明细胞肾细胞癌的进展。
Int J Biol Sci. 2025 Jun 9;21(9):3827-3851. doi: 10.7150/ijbs.113737. eCollection 2025.
5
Prognostic factors for return to work in breast cancer survivors.乳腺癌幸存者恢复工作的预后因素。
Cochrane Database Syst Rev. 2025 May 7;5(5):CD015124. doi: 10.1002/14651858.CD015124.pub2.
6
Tertiary lymphoid structures combined with biomarkers of inflammation are associated with the efficacy of neoadjuvant immunochemotherapy in resectable non-small cell lung cancer: A retrospective study.三级淋巴结构联合炎症生物标志物与可切除性非小细胞肺癌新辅助免疫化疗疗效相关:一项回顾性研究。
Thorac Cancer. 2024 Jan;15(2):172-181. doi: 10.1111/1759-7714.15175. Epub 2023 Dec 6.
7
Identification of a risk score model based on tertiary lymphoid structure-related genes for predicting immunotherapy efficacy in non-small cell lung cancer.基于三级淋巴结构相关基因的风险评分模型鉴定用于预测非小细胞肺癌免疫治疗疗效。
Thorac Cancer. 2024 May;15(14):1119-1131. doi: 10.1111/1759-7714.15299. Epub 2024 Apr 1.
8
Prehabilitation during neoadjuvant chemotherapy results in an enhanced immune response in esophageal adenocarcinoma tumors: A randomized controlled trial.新辅助化疗期间的术前康复训练可增强食管腺癌肿瘤的免疫反应:一项随机对照试验。
J Sport Health Sci. 2025 Jun 3:101063. doi: 10.1016/j.jshs.2025.101063.
9
The extra-islet pancreas supports autoimmunity in human type 1 diabetes.胰岛外胰腺在人类1型糖尿病中支持自身免疫。
Elife. 2025 Apr 15;13:RP100535. doi: 10.7554/eLife.100535.
10
Are Current Survival Prediction Tools Useful When Treating Subsequent Skeletal-related Events From Bone Metastases?当前的生存预测工具在治疗骨转移后的骨骼相关事件时有用吗?
Clin Orthop Relat Res. 2024 Sep 1;482(9):1710-1721. doi: 10.1097/CORR.0000000000003030. Epub 2024 Mar 22.

本文引用的文献

1
The hallmarks of cancer immune evasion.癌症免疫逃逸的特征。
Cancer Cell. 2024 Nov 11;42(11):1825-1863. doi: 10.1016/j.ccell.2024.09.010. Epub 2024 Oct 10.
2
Defining clinically useful biomarkers of immune checkpoint inhibitors in solid tumours.定义实体瘤中免疫检查点抑制剂的临床有用生物标志物。
Nat Rev Cancer. 2024 Jul;24(7):498-512. doi: 10.1038/s41568-024-00705-7. Epub 2024 Jun 12.
3
A blueprint for tumor-infiltrating B cells across human cancers.一份关于人类癌症中肿瘤浸润性B细胞的蓝图。
Science. 2024 May 3;384(6695):eadj4857. doi: 10.1126/science.adj4857.
4
Tertiary lymphoid structures and B cells determine clinically relevant T cell phenotypes in ovarian cancer.三级淋巴结构和 B 细胞决定卵巢癌中具有临床相关性的 T 细胞表型。
Nat Commun. 2024 Mar 21;15(1):2528. doi: 10.1038/s41467-024-46873-w.
5
Triple-negative breast cancer survival prediction using artificial intelligence through integrated analysis of tertiary lymphoid structures and tumor budding.基于三级淋巴结构和肿瘤芽生的人工智能综合分析预测三阴性乳腺癌的生存情况
Cancer. 2024 Apr 15;130(S8):1499-1512. doi: 10.1002/cncr.35261. Epub 2024 Feb 29.
6
Single-cell and spatial profiling identify three response trajectories to pembrolizumab and radiation therapy in triple negative breast cancer.单细胞和空间分析确定了三阴性乳腺癌对帕博利珠单抗和放射治疗的三种反应轨迹。
Cancer Cell. 2024 Jan 8;42(1):70-84.e8. doi: 10.1016/j.ccell.2023.12.012.
7
How chemokines organize the tumour microenvironment.趋化因子如何组织肿瘤微环境。
Nat Rev Cancer. 2024 Jan;24(1):28-50. doi: 10.1038/s41568-023-00635-w. Epub 2023 Dec 8.
8
Immunosurveillance in clinical cancer management.临床癌症管理中的免疫监测。
CA Cancer J Clin. 2024 Mar-Apr;74(2):187-202. doi: 10.3322/caac.21818. Epub 2023 Oct 25.
9
Tertiary lymphoid structures as hubs of antitumour immunity.三级淋巴结构作为抗肿瘤免疫的枢纽
Nat Rev Cancer. 2023 Dec;23(12):803. doi: 10.1038/s41568-023-00626-x.
10
Tertiary lymphoid structures and B cells: An intratumoral immunity cycle.三级淋巴结构与B细胞:肿瘤内免疫循环
Immunity. 2023 Oct 10;56(10):2254-2269. doi: 10.1016/j.immuni.2023.08.009. Epub 2023 Sep 11.